Compare IRS & PGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
IRSA Inversiones Y Representaciones S.A. Global Depositary Shares (Each representing ten shares of)
Current Price
Current Price
| Metric | IRS | PGEN |
|---|---|---|
| Founded | 1943 | 1998 |
| Country | Argentina | United States |
| Employees | N/A | N/A |
| Industry | Homebuilding | Biotechnology: Pharmaceutical Preparations |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.4B | 1.5B |
| IPO Year | 1994 | N/A |
| Metric | IRS | PGEN |
|---|---|---|
| Price | $15.90 | $4.56 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 5 |
| Target Price | N/A | ★ $7.67 |
| AVG Volume (30 Days) | 186.0K | ★ 3.6M |
| Earning Date | 02-04-2026 | 03-18-2026 |
| Dividend Yield | ★ 8.64% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 0.38 | N/A |
| Revenue | ★ $351,014,223.00 | $6,309,000.00 |
| Revenue This Year | N/A | $342.78 |
| Revenue Next Year | N/A | $478.46 |
| P/E Ratio | $3.87 | ★ N/A |
| Revenue Growth | 2.09 | ★ 59.20 |
| 52 Week Low | $10.61 | $1.11 |
| 52 Week High | $19.14 | $5.23 |
| Indicator | IRS | PGEN |
|---|---|---|
| Relative Strength Index (RSI) | 42.45 | 52.44 |
| Support Level | $15.68 | $4.22 |
| Resistance Level | $19.14 | $5.02 |
| Average True Range (ATR) | 0.91 | 0.40 |
| MACD | -0.23 | -0.04 |
| Stochastic Oscillator | 6.94 | 44.90 |
IRSA Inversiones y Representaciones SA is engaged in a diversified business. The company's operating segments include Shopping Malls, which comprise lease and service revenues principally related to the rental of commercial and other spaces in the company's shopping malls; Offices, which include lease revenues and other service revenues related to office activities; Sales and Developments, which include the development, maintenance, and sales of undeveloped parcels of land and/or trading properties; Hotels, which mainly include revenues from rooms, catering, and restaurants; and others. The company generates the majority of its revenue from the Shopping Malls segment.
Precigen Inc is a biotechnology company that develops synthetic biology solutions. The company designs build and regulate gene programs. Its technologies are broadly applicable across a wide range of diverse end markets. Intrexon's business model is to commercialize its technologies through exclusive channel collaborations with collaborators that have specific industry expertise, development resources, and sales and marketing capabilities, in order to bring new and improved products and processes to market. Its reportable segments are Biopharmaceuticals and Exemplar. The company's collaborators provide compensation through technology access fees, royalties, milestones, and reimbursement of certain costs.